{"id":298422,"date":"2026-10-09T12:54:37","date_gmt":"2026-10-09T07:24:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=298422"},"modified":"2026-10-13T12:54:10","modified_gmt":"2026-10-13T07:24:10","slug":"why-beta-drugs-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-beta-drugs-share-price-fall-today-2026\/","title":{"rendered":"Beta Drugs (BETA) Share Price Falls 9.11%: What the Latest Move Means"},"content":{"rendered":"
Beta Drugs (BETA)<\/a> share price fell to Rs 1,676.2 today, down 9.11% from the previous close. Market cap was Rs 2,168.87 crore.<\/em><\/div>\n

Beta Drugs Share Price was at Rs 1,676.2, down 9.11% from the previous close, with market capitalisation at Rs 2,168.87 crore as of 13 October 2026 at 12:53:13 PM IST. The move placed Beta Drugs Share Price firmly in focus for healthcare investors tracking intraday price action and Beta Drugs Stock News. Univest data confirms the move itself, though no company-specific trigger has been identified. The fall matters because the stock opened near the previous close, moved to an intraday high of Rs 1,859.4, and then weakened to a low of Rs 1,666.1. The latest Univest figures also show that Beta Drugs Share Price is now being read alongside valuation, earnings quality and sector comparison rather than only the day\u2019s decline.<\/p>\n

For readers following Beta Drugs Share Price Today, the key question is not only what changed on the screen, but how the move compares with the company\u2019s fundamentals and the broader pharmaceuticals & drugs set. Univest data places the stock in the Small Cap category, which helps frame the scale of the company without changing the interpretation of the price fall itself. Beta Drugs Share Price therefore draws attention as a price-action event with valuation context, not as a story built on speculation.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n